Peter Davis
Peter Davis has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Alexander D. Douglas
Jenner Institute, University of Oxford, Oxford, UK
1 shared publication Amy Bryan
Doctor, Department of Medicine for the Elderly, Queen Elizabeth University Hospital, UK
1 shared publicationAndrew Gorringe
UK Health Security Agency, Porton Down , Salisbury
1 shared publication- Calman Alexander MacLennan
Jenner Institute, Nuffield Department of Medicine, University of Oxford
1 shared publication - Cristina Alaimo
LimmaTech Biologics AG , Schlieren
1 shared publication Deborah A Williamson
School of Medicine, University of St Andrews , St Andrews
1 shared publication
Latest Publications
- Open Access
- 26 September 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Expert Consensus on Controlled Human Infection Studies for Gonorrhea
Background: Gonorrhea, a bacterial sexually transmitted infection caused by Neisseria gonorrhoeae, is a major global public health concern due to rising incidence and increasing antimicrobial resistance. Absence of a licensed vaccine and limitations of animal models have impeded progress in the understanding of pathogenesis, immunity, and development of novel therapeutics and vaccines. Controlled human infection studies (CHIS) offer a powerful approach to accelerate vaccine and antimicrobial development and improve understanding of host–pathogen interactions. Methods: An international, multidisciplinary stakeholder workshop was convened in Oxford, United Kingdom (March 2025), to review current gonorrhea CHIS activity, define research priorities, and establish consensus standards for future studies through structured discussion. Results: Consensus highlighted the continued value of CHIS with well-characterized strains such as FA1090, while supporting careful selection and characterization of novel strains. Standardized, risk-based approaches to inoculum manufacture and quality assurance were recommended to enhance reproducibility and scalability. Expansion of CHIS to include additional anatomical sites and novel populations, including individuals with female reproductive anatomy, was identified as scientifically valuable but requiring careful ethical and safety evaluation. CHIS were recognized as uniquely positioned to advance vaccine and antimicrobial development by enabling early efficacy assessment, identification of correlates of protection, and optimization of treatment and prevention strategies. Conclusions: Gonorrhea CHIS are an underutilized but valuable research tool with potential to accelerate translational research against gonorrhea. With robust ethical oversight, community engagement, and international collaboration, expanded and harmonized CHIS could substantially advance prevention and treatment strategies.
- 26 September 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Open AccessExpert Consensus on Controlled Human Infection Studies for Gonorrhea
Background: Gonorrhea, a bacterial sexually transmitted infection caused by Neisseria gonorrhoeae, is a major global public health concern due to rising incidence and increasing antimicrobial resistance. Absence of a licensed vaccine and limitations of animal models have impeded progress in the understanding of pathogenesis, immunity, and development of novel therapeutics and vaccines. Controlled human infection studies (CHIS) offer a powerful approach to accelerate vaccine and antimicrobial development and improve understanding of host–pathogen interactions. Methods: An international, multidisciplinary stakeholder workshop was convened in Oxford, United Kingdom (March 2025), to review current gonorrhea CHIS activity, define research priorities, and establish consensus standards for future studies through structured discussion. Results: Consensus highlighted the continued value of CHIS with well-characterized strains such as FA1090, while supporting careful selection and characterization of novel strains. Standardized, risk-based approaches to inoculum manufacture and quality assurance were recommended to enhance reproducibility and scalability. Expansion of CHIS to include additional anatomical sites and novel populations, including individuals with female reproductive anatomy, was identified as scientifically valuable but requiring careful ethical and safety evaluation. CHIS were recognized as uniquely positioned to advance vaccine and antimicrobial development by enabling early efficacy assessment, identification of correlates of protection, and optimization of treatment and prevention strategies. Conclusions: Gonorrhea CHIS are an underutilized but valuable research tool with potential to accelerate translational research against gonorrhea. With robust ethical oversight, community engagement, and international collaboration, expanded and harmonized CHIS could substantially advance prevention and treatment strategies.
- Open Access
- 28 April 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (5)
Two-Year Outcomes of Postoperative Spine Infection: Implant Retention and Predictors of Treatment Failure
Background: Postoperative spine infection (PSI) after surgery occurs in approximately 1%–2% of cases and is associated with significant morbidity. High-quality evidence to guide optimal prevention and management of PSI is limited. Methods: We retrospectively identified all adult patients over a 3-year period (2020–2023) who required reoperation for deep PSI. Clinical, microbiological therapy, and 24-month outcome data were collected. Treatment failure was defined as unplanned return to the operating room secondary to persistent infection or infection-related implant failure requiring removal. Descriptive statistics and univariate logistic regression were used to identify factors associated with failure. Results: Sixty-three deep PSI cases were identified (range 18–91 years, median 59 years, 56% female). Onset of infection ranged from 4 days to 30 weeks postoperatively (median 20 days). Staphylococcus aureus and Enterobacterales were the most common pathogens, followed by coagulase-negative staphylococci and Cutibacterium acnes. Treatment failure occurred in 13 cases (21%). In cases where implants were present (81% of total cohort), planned antibiotic durations of either 12 weeks or 24 weeks demonstrated similar success rates (P = .76). Infections involving Cutibacterium acnes were more likely associated with implant removal (P = .04). No other significant risk factors for failure were identified. Conclusions: Most PSIs were effectively managed in this cohort with surgical debridement and targeted antibiotics, allowing implant retention in most patients with instrumentation.
- 28 April 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (5)
Open AccessTwo-Year Outcomes of Postoperative Spine Infection: Implant Retention and Predictors of Treatment Failure
Background: Postoperative spine infection (PSI) after surgery occurs in approximately 1%–2% of cases and is associated with significant morbidity. High-quality evidence to guide optimal prevention and management of PSI is limited. Methods: We retrospectively identified all adult patients over a 3-year period (2020–2023) who required reoperation for deep PSI. Clinical, microbiological therapy, and 24-month outcome data were collected. Treatment failure was defined as unplanned return to the operating room secondary to persistent infection or infection-related implant failure requiring removal. Descriptive statistics and univariate logistic regression were used to identify factors associated with failure. Results: Sixty-three deep PSI cases were identified (range 18–91 years, median 59 years, 56% female). Onset of infection ranged from 4 days to 30 weeks postoperatively (median 20 days). Staphylococcus aureus and Enterobacterales were the most common pathogens, followed by coagulase-negative staphylococci and Cutibacterium acnes. Treatment failure occurred in 13 cases (21%). In cases where implants were present (81% of total cohort), planned antibiotic durations of either 12 weeks or 24 weeks demonstrated similar success rates (P = .76). Infections involving Cutibacterium acnes were more likely associated with implant removal (P = .04). No other significant risk factors for failure were identified. Conclusions: Most PSIs were effectively managed in this cohort with surgical debridement and targeted antibiotics, allowing implant retention in most patients with instrumentation.
- 20 August 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Doxycycline Post-exposure Prophylaxis and Off-target Antimicrobial Resistance: Potential Amplification Within Sexual Networks
Doxycycline post-exposure prophylaxis is now included in many clinical guidelines, yet concerns remain regarding antimicrobial resistance, particularly off-target effects on commensal bacteria in the oropharynx, with intimate behaviours potentially facilitating resistance transmission within sexual networks.
- 20 August 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Doxycycline Post-exposure Prophylaxis and Off-target Antimicrobial Resistance: Potential Amplification Within Sexual Networks
Doxycycline post-exposure prophylaxis is now included in many clinical guidelines, yet concerns remain regarding antimicrobial resistance, particularly off-target effects on commensal bacteria in the oropharynx, with intimate behaviours potentially facilitating resistance transmission within sexual networks.
- Open Access
- 11 October 2020
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 66 (2) , 89-97
Atypical presentations in the hospitalised older adult testing positive for SARS-CoV-2: a retrospective observational study in Glasgow, Scotland
Introduction: Understanding of how SARS-CoV-2 manifests itself in older adults was unknown at the outset of the pandemic. We undertook a retrospective observational analysis of all patients admitted to older people’s services with confirmed COVID-19 in one of the largest hospitals in Europe. We detail presenting symptoms, prognostic features and vulnerability to nosocomial spread. Methods: We retrospectively collected data for each patient with a positive SARSCoV-2 RT PCR between 18th March and the 20th April 2020 in a department of medicine for the elderly in Glasgow. Results: 222 patients were included in our analysis. Age ranged from 56 to 99 years (mean = 82) and 148 were female (67%). 119 patients had a positive swab for SARS-CoV-2 within the first 14 days of admission, only 32% of these patients presented with primarily a respiratory type illness. 103 patients (46%) tested positive after 14 days of admission – this was felt to represent likely nosocomial infection. 95 patients (43%) died by day 30 after diagnosis. Discussion: This data indicates that older people were more likely to present with non-respiratory symptoms. High clinical frailty scores, severe lymphopenia and cumulative comorbidities were associated with higher mortality rates. Several contributing factors will have led to nosocomial transmission.
- 11 October 2020
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 66 (2) , 89-97
Open AccessAtypical presentations in the hospitalised older adult testing positive for SARS-CoV-2: a retrospective observational study in Glasgow, Scotland
Introduction: Understanding of how SARS-CoV-2 manifests itself in older adults was unknown at the outset of the pandemic. We undertook a retrospective observational analysis of all patients admitted to older people’s services with confirmed COVID-19 in one of the largest hospitals in Europe. We detail presenting symptoms, prognostic features and vulnerability to nosocomial spread. Methods: We retrospectively collected data for each patient with a positive SARSCoV-2 RT PCR between 18th March and the 20th April 2020 in a department of medicine for the elderly in Glasgow. Results: 222 patients were included in our analysis. Age ranged from 56 to 99 years (mean = 82) and 148 were female (67%). 119 patients had a positive swab for SARS-CoV-2 within the first 14 days of admission, only 32% of these patients presented with primarily a respiratory type illness. 103 patients (46%) tested positive after 14 days of admission – this was felt to represent likely nosocomial infection. 95 patients (43%) died by day 30 after diagnosis. Discussion: This data indicates that older people were more likely to present with non-respiratory symptoms. High clinical frailty scores, severe lymphopenia and cumulative comorbidities were associated with higher mortality rates. Several contributing factors will have led to nosocomial transmission.